Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00510302
Status:
COMPLETED
Last Update Posted:
2020-09-16
First Post:
2007-07-31
Brief Title:
Melanoma Risk-Reduction Among Patients and Family Members
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Study Overview
Official Title:
Melanoma Risk-Reduction Practices Among Melanoma Patients and Their Family Members
Status:
COMPLETED
Status Verified Date:
2020-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Primary Objectives
To conduct semi-structured interviews with melanoma patients and family members to collect descriptive information on their UVR exposure UVR exposure-reduction practices melanoma early detection practices knowledge psychosocial variables related to melanoma risk-reduction eg self-efficacy norms and expectations and experiences surrounding the diagnosis of melanoma in the family Melanoma patients and family members with children will be asked about the UVR exposure and UVR exposure-reduction practices of their children and parental practices to reduce UVR exposure among children
To develop behavioral and attitudinal questionnaires based on data collected during semi-structured interviews and evaluate the appropriateness of these questionnaires using cognitive interviewing techniques
To develop tailored messages aimed at promoting strategies to reduce UVR exposure eg wearing protective clothing minimizing midday UVR exposure minimizing duration of UVR exposure using shade and sunscreen avoiding sun lamps and avoiding intentional tanning and improving adherence to surveillance and screening guidelines Messages will be developed to correspond to responses to questionnaire items
To assess tailored messages for their relevance appropriateness attractiveness and appeal credibility and perceived behavioral impact among melanoma patients and their family members
To conduct semi-structured interviews with melanoma patients and family members to collect descriptive information on their UVR exposure UVR exposure-reduction practices melanoma early detection practices knowledge psychosocial variables related to melanoma risk-reduction eg self-efficacy norms and expectations and experiences surrounding the diagnosis of melanoma in the family Melanoma patients and family members with children will be asked about the UVR exposure and UVR exposure-reduction practices of their children and parental practices to reduce UVR exposure among children
To develop behavioral and attitudinal questionnaires based on data collected during semi-structured interviews and evaluate the appropriateness of these questionnaires using cognitive interviewing techniques
To develop tailored messages aimed at promoting strategies to reduce UVR exposure eg wearing protective clothing minimizing midday UVR exposure minimizing duration of UVR exposure using shade and sunscreen avoiding sun lamps and avoiding intentional tanning and improving adherence to surveillance and screening guidelines Messages will be developed to correspond to responses to questionnaire items
To assess tailored messages for their relevance appropriateness attractiveness and appeal credibility and perceived behavioral impact among melanoma patients and their family members
Detailed Description:
Participants in Part 1 of the study will be asked to be interviewed about topics related to melanoma risk-reduction including opinions attitudes beliefs and practices related to ultraviolet radiation exposure melanoma prevention and melanoma detection
Participants in Part 2 of the study will be asked to complete a written questionnaire on melanoma risk-reduction and then be interviewed to obtain feedback on how the questionnaire may be refined
Participants in Part 3 of the study will be asked to be interviewed by telephone Participants then will receive educational material in the form of a newsletter tailored to their interview responses Participants then will be asked to be interviewed to obtain feedback for refining the educational material In each part of the study the patientfamily member will receive a letter describing the study and the Consent Statement for Questionnaire and Interview Studies
Prior to the start of the interview the Consent Statement will be read to the patientfamily member Patientsfamily members may or may not choose to have the interview tape-recorded Participants may stop the interview or questionnaire at any time and may refuse to answer any questions At any time the patientfamily member may refuse to have the interview tape-recorded There is no treatment associated with this study
Participants in Part 2 of the study will be asked to complete a written questionnaire on melanoma risk-reduction and then be interviewed to obtain feedback on how the questionnaire may be refined
Participants in Part 3 of the study will be asked to be interviewed by telephone Participants then will receive educational material in the form of a newsletter tailored to their interview responses Participants then will be asked to be interviewed to obtain feedback for refining the educational material In each part of the study the patientfamily member will receive a letter describing the study and the Consent Statement for Questionnaire and Interview Studies
Prior to the start of the interview the Consent Statement will be read to the patientfamily member Patientsfamily members may or may not choose to have the interview tape-recorded Participants may stop the interview or questionnaire at any time and may refuse to answer any questions At any time the patientfamily member may refuse to have the interview tape-recorded There is no treatment associated with this study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None